Dr. Celano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-520-5000
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Neurological Surgery, 2017 - 2024
- Emory University School of MedicineInternship, Surgery, 2016 - 2017
- Emory UniversityMD, Neurosurgery, 2012 - 2016
- Emory University School of MedicineClass of 2016
Certifications & Licensure
- WA State Medical License 2024 - 2026
- DC State Medical License 2017 - 2024
Publications & Presentations
PubMed
- 61 citationsSpinal cord ependymoma: a review of the literature and case series of ten patientsEmma C. Celano, Arsalaan Salehani, James G. Malcolm, Erik Reinertsen, Constantinos G. Hadjipanayis
Journal of Neuro-Oncology. 2016-05-06 - 57 citationsPerception of passage through openings depends on the size of the body in motion.John M. Franchak, Emma C. Celano, Karen E. Adolph
Experimental Brain Research. 2012-09-19 - 19 citationsPhase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastomaD Jay McCracken, Emma C. Celano, Alfredo Voloschin, William L. Read, Jeffrey J. Olson
Journal of Neuro-Oncology. 2016-08-09
Journal Articles
- Spinal cord ependymoma: a review of the literature and case series of ten patientsCelano EC, Salehani A, Malcolm JG, Reinertsen E, Hadjipanayis CG, Journal of Neuro-Oncology, 5/6/2016
- Perception of passage through openings depends on the size of the body in motionFranchak JM, Celano EC, Adolph KE, Experimental Brain Research, 9/19/2012
Abstracts/Posters
- Phase I Trial of Dose-Escalating Temozolomide Plus Bevacizumab and Bortezomib for Progressive GlioblastomaMcCracken DJ, Celano EC, Voloschin A, Read W, Olson JJ, AANS Annual Scientific Meeting, Chicago, IL, 5/2/2016
- Phase I Trial of Dose-Escalating Temozolomide Plus Bevacizumab and Bortezomib for Progressive GlioblastomaMcCracken DJ, Celano EC, Voloschin A, Read W, Olson JJ, Georgia Neurosurgical Society Fall Meeting, Georgia, 12/5/2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: